Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-87.43%
operating margin TTM
-73.07%
revenue TTM
10.86 Million
revenue per share TTM
1.27$
valuation ratios | |
|---|---|
| pe ratio | -0.62 |
| peg ratio | -3.03 |
| price to book ratio | -0.29 |
| price to sales ratio | 0.53 |
| enterprise value multiple | 1.03 |
| price fair value | -0.29 |
profitability ratios | |
|---|---|
| gross profit margin | 95.93% |
| operating profit margin | -73.07% |
| pretax profit margin | -87.43% |
| net profit margin | -87.43% |
| return on assets | -129.5% |
| return on equity | 55.38% |
| return on capital employed | -1147.59% |
liquidity ratios | |
|---|---|
| current ratio | 1.03 |
| quick ratio | 0.98 |
| cash ratio | 0.43 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 249.76 |
| operating cycle | 331.39 |
| days of payables outstanding | 339.56 |
| cash conversion cycle | -8.17 |
| receivables turnover | 4.47 |
| payables turnover | 1.07 |
| inventory turnover | 1.46 |
debt and solvency ratios | |
|---|---|
| debt ratio | 2.04 |
| debt equity ratio | -0.73 |
| long term debt to capitalization | -1.91 |
| total debt to capitalization | -2.70 |
| interest coverage | -2.37 |
| cash flow to debt ratio | -0.43 |
cash flow ratios | |
|---|---|
| free cash flow per share | -9.62 |
| cash per share | 5.29 |
| operating cash flow per share | -9.63 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.43 |
| short term coverage ratios | -6.11 |
| capital expenditure coverage ratio | -1,575.30 |
Frequently Asked Questions
When was the last time Karyopharm Therapeutics Inc. (NASDAQ:KPTI) reported earnings?
Karyopharm Therapeutics Inc. (KPTI) published its most recent earnings results on 03-11-2025.
What is Karyopharm Therapeutics Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Karyopharm Therapeutics Inc. (NASDAQ:KPTI)'s trailing twelve months ROE is 55.38%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Karyopharm Therapeutics Inc. (KPTI) currently has a ROA of -129.5%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did KPTI's net profit margin stand at?
KPTI reported a profit margin of -87.43% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is KPTI's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.03 in the most recent quarter. The quick ratio stood at 0.98, with a Debt/Eq ratio of -0.73.